• PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

CMA welcomes new approval pathway as part of a world class regulatory regime

16 Feb 2018 1:27 PM | Anonymous

Mr Carl Gibson, ceo of Complementary Medicines Australia (CMA) said: “We applaud the continued implementation of the government agreed recommendations from the Medicines and Medical Devices Review (MMDR), including amendments to provide a new approval pathway for listing complementary medicines with higher therapeutic indications and health claims.”

To read more click here

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software